Similar Search Results

An empirical model of drug pricing and competition: a dynamic perspective

Camejo, Rodrigo Refoios; McGrath, Clare; Rutten, Frans F.H. - In: International Journal of Economics and Business Research 6 (2013) 2, pp. 173-193

In this study we test the impact of competition and other market attributes on the pricing of pharmaceuticals. Three …

Persistent link: https://www.econbiz.de/10010684350

Pricing and reimbursement of pharmaceuticals in Italy

Folino-Gallo, Pietro; Montilla, Simona; Bruzzone, Mario; … - In: The European Journal of Health Economics 9 (2008) 3, pp. 305-310

Persistent link: https://www.econbiz.de/10005391160

External Price Benchmarking vs. Price Negotiation for Pharmaceuticals

Ackermann, Philipp - Department Volkswirtschaftlehre, Universität Bern - 2010

External price benchmarking imposes a price cap for pharmaceuticals based on prices of identical products in other …

Persistent link: https://www.econbiz.de/10008570656

Pharmaceutical Pricing and Reimbursement Policies in Canada

Paris, Valérie; Docteur, Elizabeth - Directorate for Employment, Labour and Social Affairs … - 2006

This paper describes and assesses pharmaceutical pricing and reimbursement policies in Canada, considering them in the context of the broader policy and market environment in which they operate, and investigating their role in contributing to Canada’s achievements in meeting a range of...

Persistent link: https://www.econbiz.de/10005049185

Pharmaceutical Pricing and Reimbursement Policies in Sweden

Moïse, Pierre; Docteur, Elizabeth - Directorate for Employment, Labour and Social Affairs … - 2007

to low mark-ups in the distribution chain and no VAT for prescribed medicines, Sweden's public prices for pharmaceuticals … national income to pharmaceuticals. What limited evidence exists tends to suggest that relatively low pharmaceutical … reimbursement status of new pharmaceuticals and mandatory substitution of the lowest-cost generic alternative. The use of cost …

Persistent link: https://www.econbiz.de/10005049187

Pharmaceutical Pricing and Reimbursement Policies in Slovakia

Kaló, Zoltán; Docteur, Elizabeth; Moïse, Pierre - Directorate for Employment, Labour and Social Affairs … - 2008

income going to pharmaceuticals is exceeded only in Hungary. Although its relatively low national income is a partial … social insurance scheme, the cost-effectiveness of new pharmaceuticals is not assessed. On the other hand, certain policy …

Persistent link: https://www.econbiz.de/10005049192

Pharmaceutical Pricing and Reimbursement Policies in Switzerland

Paris, Valérie; Docteur, Elizabeth - Directorate for Employment, Labour and Social Affairs … - 2007

This paper examines aspects of the policy environment and market characteristics of the Swiss pharmaceutical sector, and assesses the degree to which Switzerland has achieved certain policy goals. In Switzerland, pharmaceutical spending has not been growing faster than health expenditure as a...

Persistent link: https://www.econbiz.de/10005049210

Extraordinary Pricing of Orphan Drugs: Is it a Socially Responsible Strategy for the U.S. Pharmaceutical Industry?

Hemphill, Thomas - In: Journal of Business Ethics 94 (2010) 2, pp. 225-242

Persistent link: https://www.econbiz.de/10008526606

Global pharmaceutical pricing strategies: profit implications of price discounting

Longo, Christopher J. - In: International Journal of Economics and Business Research 2 (2010) 6, pp. 447-460

Global pharmaceutical pricing strategies have been debated in published literature; however, these debates have not accounted for the differences in elasticity of demand between the public, private and cash paying markets. A mathematical model is presented that explores several plausible...

Persistent link: https://www.econbiz.de/10008755174

Price Regulation and Parallel Imports of Pharmaceuticals.

Brekke, Kurt R.; Holmås, Tor Helge; Straume, Odd Rune - Institutt for samfunnsøkonomi, Norges Handelshøyskole … - 2014

This paper studies the effects of price regulation and parallel imports in the on-patent pharmaceutical market. First, we develop a theory model in which a pharmacy negotiates producer prices with a brand-name firm and then sets retail prices. We show that the effects of price regulation...

Persistent link: https://www.econbiz.de/10010818874

1
2
3
4
5
6
7
8
9
10
Next
Last